TrialCNS neuroscience & therapeutics2016

Rivastigmine Patch in Chinese Patients with Probable Alzheimer's disease: A 24-week, Randomized, Double-Blind Parallel-Group Study Comparing Rivastigmine Patch (9.5 mg/24 h) with Capsule (6 mg Twice Daily).

Zhen-Xin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.